Article Versions Notes

Hazini A, Dieringer B, Klingel K, Pryshliak M, Geisler A, Kobelt D, Daberkow O, Kurreck J, Linthout Sv, Fechner H. Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H. Viruses. 2021; 13(10):1918. https://doi.org/10.3390/v13101918

Hazini, Ahmet, Babette Dieringer, Karin Klingel, Markian Pryshliak, Anja Geisler, Dennis Kobelt, Ole Daberkow, Jens Kurreck, Sophie van Linthout, and Henry Fechner. 2021. "Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H" Viruses 13, no. 10: 1918. https://doi.org/10.3390/v13101918

Hazini, A., Dieringer, B., Klingel, K., Pryshliak, M., Geisler, A., Kobelt, D., Daberkow, O., Kurreck, J., Linthout, S. v., & Fechner, H. (2021). Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H. Viruses, 13(10), 1918. https://doi.org/10.3390/v13101918